# Mission Status

## Completed
- M01 — Foundation + Constitution: IMPLEMENTED (prototype scope)
- M02 — Adaptive Question Planner v1: IMPLEMENTED
- M03 — Versioned Rule Registry: IMPLEMENTED
- M04 — Evidence Graph + Finding Model: IMPLEMENTED
- M05 — Screening & Test Priority Engine: IMPLEMENTED
- Strategic Review 1: COMPLETE — CONTINUE WITH CHANGES
- M05.1 — Core Verification Harness: IMPLEMENTED
- M06 — Safety Gate + Clinical Source Baseline: IMPLEMENTED
- M07 — Health Map UX v2 + Shared Presentation Model: IMPLEMENTED
- M08 — Lab Reassessment + Normalization/Freshness: IMPLEMENTED
- M09 — Recommendation Engine v1: IMPLEMENTED
- Strategic Review 2: COMPLETE — CONTINUE WITH CHANGES

## SR2 closure
- Deterministic evidence/reassessment/action architecture remains the core product thesis.
- M08/M09 established a useful Assess → Measure → Reassess → Act loop.
- Found a blocker before AI: population applicability is not yet first-class across findings/investigations/recommendations.
- Found a blocker before AI: raw questionnaire `hba1c` / `b12` values can bypass normalized lab date/source/verification/freshness provenance.
- Investigation planning must become safety/applicability-aware rather than relying only on downstream recommendation caution.
- Contradictory multi-select states such as `none + condition/symptom` must be normalized/validated.
- Clinical governance should expand to recommendation and applicability/safety artifacts.
- M10 is retained but changed to a HIGH-effort privacy/evaluation-first AI mission.
- M11 is conditional on M10 proving incremental utility and is reframed as comparison/safe escalation rather than an authoritative merged verdict.
- If AI utility is weak, M13 Longitudinal Health moves ahead of M11.
- Broad domain expansion remains frozen through M09.1 + M10 AI Utility Gate.

## Current
M09.1 — Clinical Applicability & Evidence Integrity Gate: NEXT
Effort: High

## Then
M10 — AI Harness Runtime + Privacy/Evaluation: High
AI Utility Gate — part of M10 closure
M11 — AI Review Comparison & Safe Escalation: High, CONDITIONAL
M13 — Longitudinal Health + Persistence: Medium/High; move ahead if AI utility is weak

## Active SR2 constraints
- No adult-oriented rule/test mapping may silently run in an unsupported population.
- One canonical normalized lab-ingestion path must drive lab-informed findings.
- Investigation planning must respect applicability/safety, not only missing evidence.
- Normalize contradictory inputs before rule execution.
- AI must not treat stale/unverified/ineligible lab records as active evidence.
- AI must not upgrade prototype logic to clinical authority.
- Live AI data sharing must be opt-in and minimized.
- Deterministic urgent/safety restrictions remain authoritative.
- M11 proceeds only if M10 proves incremental review value.
- Do not introduce a generic overall health score.

## Execution agreement
- Repository: `Amonaval/jaanch`
- Commit budget: 1–2 commits per mission
- Default effort: Medium
- Safety/applicability/AI/reconciliation missions use High effort.
- Strategic reviews may continue, change, drop or defer roadmap work.
